Compare ImmunityBio Inc. Common Stock (IBRX) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs NRG Energy Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while NRG Energy Inc trades at $106.74 (market cap $22.83B). The key difference: NRG Energy Inc is far larger — about 2.2× ImmunityBio Inc. Common Stock's market cap, and NRG Energy Inc pays a 1.75% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and NRG Energy Inc for 62 Days on average.
| IBRX | NRG | |
|---|---|---|
Market Cap | $10.33B | $22.83B |
Volume | 11,745,198 | 5,365,870 |
Sector | Health | Utilities |
52-Week High | $11.55 | $184.03 |
52-Week Low | $1.98 | $95.23 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $10.79B | $46.79B |
Dividend Yield | — | 1.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NRG Energy trades at $108.61, up 4.84% with bullish technical signals and strong analyst support. The stock shows robust fundamentals with $30.71B revenue, 2.56% net margin, and attractive valuation at P/E 28.28 and P/S 0.66. Recent developments include a transformative 1.2 GW Texas data center power project and LS Power acquisition driving growth. Cash flow trends improved significantly from 2023's negative $1.5B to 2025's positive $3.83B, though 2026 projects a temporary dip.
Outlook remains positive with 70% analyst buy ratings and $202.90 consensus target representing 87% upside. Key opportunities include data center expansion and customer-backed power projects, while risks involve elevated debt levels (56.42% debt-to-asset ratio) and recent earnings misses. The stock presents growth potential but requires monitoring of execution on major capital projects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
